外体miR-133b-3p调节TGF-β1/Treg免疫调节以改善骨质疏松症的发生
Yun Zhao1, Xingyao Yang1, Jialun Wang1
1Geriatric Diseases Institute of Chengdu, Department of Orthopedics, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.
Bone
|September 25, 2025
概括
骨髓介质干细胞衍生的外体 miR-133b-3p 显示出治疗骨质疏松症 (OP) 的前景. 这种疗法向TGF-β1 / Treg免疫通路,改善骨密度并减少大鼠模型中的骨损失.
科学领域:
- 生物医学科学 生物医学科学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨质疏松症 (OP) 的发病包括调节失调的microRNAs (miRNAs) 影响骨质细胞分化.
- 在OP中miRNA参与的具体机制需要进一步阐明.
- 骨髓介质干细胞 (BMSC) 和它们衍生的外体细胞参与再生过程.
研究的目的:
- 为了研究从BMSCs出生的外体miR-133b-3p在骨质疏松症中的作用.
- 探索miR-133b-3p对OP中TGF-β1/Treg介导免疫通路的影响.
- 评估外体 miR-133b-3p 在骨质疏松症治疗中的治疗潜力.
主要方法:
- 生物信息学分析确定了差异表达的miRNA和预测的点,突出了miR-133b-3p和TGF-β1.1.
- 通过卵巢切除建立了一种骨质疏松症大鼠模型;BMSC和外体被隔离和表征.
- 在体内研究涉及用miR-133b-3p丰富的外体对待大鼠,评估骨矿物质密度和微CT参数.
- 在体外实验中检查了TGF-β1表达和Treg细胞分化的反应对外体miR-133b-3p.
主要成果:
- miR-133b-3p表达在骨质疏松性大鼠的外体内显著下降.
- 外体的miR-133b-3p直接向TGF-β1,通过双露西法酶试验证实了这一点.
- 在体内使用外体miR-133b-3p治疗改善了骨度指标 (BMD,BV/TV,Tb.N,Tb.Th) 和减少了骨质细胞标记物 (TRAP,MMP-9,Cathepsin K).
- 外体 miR-133b-3p 在体外促进了TGF-β1表达和Treg细胞分化.
结论:
- 来自BMSCs的外体miR-133b-3p有效地减轻了老鼠模型中的骨质疏松症.
- 治疗效果通过TGF-β1/Treg免疫通路进行介导.
- 外体miR-133b-3p代表了对骨质疏松症的有前途的治疗策略.
相关概念视频
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
01:31Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
01:40Bone Remodeling
40.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K